Nonsteroidal Anti-Inflammatory Drug–Induced Hepatotoxicity
Section snippets
Epidemiology
Because the relatively high-risk agents causing hepatotoxicity have been replaced by apparently safer drugs, relatively rare adverse reactions to commonly prescribed low-risk agents have become the most important cause of liver injury. This is exemplified by NSAIDs that are among the most common drugs causing idiosyncratic hepatotoxicity in several recently published series (Table 1) [7], [8], [9], [10], [11], [12], [13]. Despite these reports highlighting the importance of NSAIDs as a cause of
Sulindac
Among NSAIDs, sulindac has been the drug most consistently associated with hepatotoxicity. By 1993 there had been 91 cases of liver injury reported to the FDA with 43% showing a cholestatic pattern of liver blood test abnormalities, 25% a hepatocellular pattern, and the rest a mixed pattern [23]. In these reports the female/male ratio was 3.5:1 and 69% were over the age of 50 years. Most patients (67%) were jaundiced and four patients died. Features of hypersensitivity, such as fever, rash, and
Diclofenac-induced liver injury: a paradigm of idiosyncratic hepatotoxicity
Diclofenac is a widely prescribed NSAID, which can cause rare, but potentially serious, hepatotoxicity. Because of its widespread use, diclofenac hepatotoxicity has been one of the most common causes of hepatic adverse drug reactions, with 180 confirmed cases reported to the FDA during the first 3 years of marketing [19]. Consistent with its worldwide exposure and its association with liver injury, diclofenac on its own is among the most common drugs associated with idiosyncratic hepatotoxicity
The importance of nonsteroidal anti-inflammatory drug–induced liver injury
Because of their common use, NSAIDs contribute significantly to the overall burden of drug-induced liver injury. The importance of any drug as a cause of liver injury lies not in the overall number of cases, however, but in the severity of some reactions. Despite the availability of liver transplantation, 26% (95% CI, 13%–43%) of those who develop jaundice caused by severe NSAID-induced hepatotoxicity die [60]. Adverse hepatic reactions can mimic a wide spectrum of hepatobiliary diseases. Early
References (60)
- et al.
Incidence of drug-induced hepatic injuries: a French population-based study
Heptology
(2002) - et al.
Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs
J Hepatol
(2002) - et al.
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period
Gastroenterology
(2005) - et al.
Suspected drug-induced liver fatalities reported to the WHO database
Dig Liver Dis
(2006) Gastrointestinal effects of NSAIDs and coxibs
J Pain Symptom Manage
(2003)- et al.
Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the food and drug administration as adverse reactions
Hepatology
(1995) - et al.
Sulindac-associated hepatic injury: analysis of 91 cases reported to the food and drug administration
Gastroenterology
(1993) - et al.
Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats
Gastroenterology
(1999) - et al.
Nimesulide-induced acute hepatitis: evidence from six cases
J Hepatol
(1998) - et al.
Fatal hepatitis associated with nimesulide
J Hepatol
(2000)
COX 2 inhibitor and fulminant hepatic failure
Lancet
Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series
Am J Gastroenterol
Inhibition of mitochondrial ß–oxidation as a mechanism of hepatotoxicity
Pharmacol Ther
Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver
Life Sci
Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity
Toxicol Appl Pharmacol
Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways
Biochem Pharmacol
Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8 and ABCC2 genotypes
Gastroenterology
Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes
Toxicol Appl Pharmacol
Cytotoxic activity of T cells and non-T cells from diclofenac-immunised mice against cultured syngeneic hepatocytes exposed to diclofenac
Hepatology
Sensitivity to a metabolite of diclofenac as a cause of acute immune haemolytic anaemia
Blood
Prescription and non-prescription analgesic use among the US adult population: results from the third National health and nutritional examination survey (NHANES III)
Pharmacoepidemiol Drug Saf
Clinical toxicity: could it have been predicted? Pre-marketing experience
Drug-induced hepatic injury
Bromfenac withdrawal
WHO Drug Inf
Hepatotoxicity associated with nimesulide: data from the Spanish pharmacovigilance system
Clin Pharmacol Ther
Comparison of two clinical scales for causality assessment in hepatotoxicity
Hepatology
Incidence of drug-induced liver injury in medical inpatients
Eur J Clin Pharmacol
Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
Scand J Gastroenterol
Systematic review: the hepatotoxicity of non-steroidal anti-inflamatory drugs
Aliment Pharmacol Ther
Cited by (137)
How Are Adjuvant Medications Such as Corticosteroids and NSAIDs Used for Pain Management?
2023, Evidence-Based Practice of Palliative Medicine, Second EditionAmelioration of the hepatotoxic effects of nonsteroidal drugs using vitamin C and determination of their relationship with the lipid profile
2022, Journal of Taibah University Medical SciencesBombax Costatum extract abrogates piroxicam-mediated hepatic and gastric toxicities in rats
2020, Annales Pharmaceutiques FrancaisesHepatoprotective role of thymol in drug-induced gastric ulcer model
2018, Annals of HepatologySafety assessment of vitacoxib: 180-day chronic oral toxicity studies
2018, Regulatory Toxicology and PharmacologyCitation Excerpt :Indeed, it has been documented that coxib-induced hepatotoxicity includes genetic susceptibility to coxib-induced liver damage. On the other hand, a number of NSAIDs have been withdrawn from the human market due to liver failure (Aithal and Day, 2007). Meanwhile, the despair findings of stomach were noted, such as epithelial cells of gastric mucosa shed at 30 mg/kg bw groups on Day 180 (Fig. 3H).
Patients with naproxen-induced liver injury display T-cell memory responses toward an oxidative (S)-O-desmethyl naproxen metabolite but not the acyl glucuronide
2024, Allergy: European Journal of Allergy and Clinical Immunology